A targeted educational intervention increases oral anticoagulation rates in high-risk atrial fibrillation patients

被引:1
|
作者
Dutta, Roop [1 ]
Ryan, John G. [1 ]
Hurley, Sally [1 ]
Wylie, John [1 ,2 ]
机构
[1] St Elizabeths Med Ctr, Boston, MA USA
[2] Pfizer Inc, New York, NY USA
来源
HEART RHYTHM O2 | 2024年 / 5卷 / 05期
关键词
Atrial fibrillation; Educational intervention; Oral anticoagulation; Population health; Primary care; Quality improvement; CARE;
D O I
10.1016/j.hroo.2024.04.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Anticoagulation is the cornerstone of atrial fibrillation (AF) management for stroke prevention. Recently, we showed that oral anticoagulation (OAC) rates of AF patients in a large U.S. multispecialty health system are >80%. Objective The purpose of this study was to improve OAC rates in AF patients via an educational intervention targeted to primary care providers with low OAC rates. Methods Primary care clinicians were stratified by proportions of their AF patients at elevated stroke risk not taking anticoagulation medication. Clinicians with the lowest rates of anticoagulation were assigned to a target group receiving an educational program consisting of E-mail messaging summarizing anticoagulation guidelines. All other clinicians were assigned to a comparison group (CG). Data from a 6-month lead-in phase were compared with a 6-month follow-up period to determine whether the proportion of AF patients treated with OACs had changed. Results Of the 141 primary care clinicians with patients who met the inclusion criteria, 36 (25.53%) were assigned to the educational group (EG) and 105 (74.47%) to the CG. At baseline, there was a significant difference in percent of high-risk AF patients who were untreated in the EG (20.65%) compared to the high-risk patients who were untreated in the CG (13.64%; P = .001). After the educational intervention, high-risk AF patients without anticoagulation decreased in both EG (15.47%; P = .047) and CG (10.14%; P = .07), with greater absolute reduction in the EG (5.19% vs 3.50%). Conclusion A targeted education program was associated with increased anticoagulation rates for AF patients at high risk for stroke.
引用
收藏
页码:294 / 300
页数:7
相关论文
共 50 条
  • [1] Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillation
    Arbel, Ronen
    Sergienko, Ruslan
    Hammerman, Ariel
    Dotan-Greenberg, Sari
    Batat, Erez
    Avnery, Orly
    Greenberg, Dan
    Ellis, Martin H.
    HEART, 2019, 105 (19) : 1487 - 1492
  • [2] Primary care atrial fibrillation (PCAF) service increases anticoagulation therapy in high-risk AF patients
    Gupta, D.
    Panter, L.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 70 - 70
  • [3] HIGH RATES OF ORAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS AT A SAFETY NET INSTITUTION
    Leon, Benjamin
    Valdez, Carolyn A.
    Hanratty, Rebecca
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S148 - S149
  • [4] Trial of an educational intervention for patients with atrial fibrillation to improve anticoagulation control
    Danielle, Smith E.
    Helen, Pattison M.
    Christian, Borg Xuereb
    Gregory, Lip Y. H.
    PSYCHOLOGY & HEALTH, 2011, 26 : 276 - 276
  • [5] Rates and Predictors of Treatment With Oral Anticoagulant in Patients Newly Diagnosed With Atrial Fibrillation at High-Risk for Stroke
    Manning, Evan
    Burns, Kelley
    Laurie, Melissa
    Luke, Patten
    Ho, Michael
    Sandhu, Amneet
    CIRCULATION, 2021, 144
  • [6] Oral Anticoagulation Use in High-Risk Patients Is Improved by Elimination of False-Positive and Inactive Atrial Fibrillation Cases
    Naccarelli, Gerald V.
    Ruzieh, Mohammed
    Wolbrette, Deborah L.
    Sendra-Ferrer, Mauricio
    Van Harskamp, John
    Bentz, Barbara
    Caputo, Gregory
    McConkey, Nathan
    Mills, Kevin
    Wasemiller, Stephen
    Plamenac, Jovan
    Leslie, Douglas
    Glasser, Frendy D.
    Abendroth, Thomas W.
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (06): : E366 - E373
  • [7] Dronedarone in high-risk patients with atrial fibrillation
    Kirchhof, P.
    Nitschmann, S.
    INTERNIST, 2012, 53 (10): : 1248 - 1250
  • [8] Thromboembolism vs anticoagulation intensity in high-risk patients with atrial fibrillation: The stroke prevention in atrial fibrillation (SPAF) III study
    Wilson, DB
    McBride, R
    CIRCULATION, 1996, 94 (08) : 187 - 187
  • [9] Thrombocytopenia in Patients With Atrial Fibrillation on Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
    Kiviniemi, Tuomas
    Karjalainen, Pasi
    Rubboli, Andrea
    Schlitt, Axel
    Tuomainen, Petri
    Niemela, Matti
    Laine, Mika
    Biancari, Fausto
    Lip, Gregory Y. H.
    Airaksinen, K. E. Juhani
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (04): : 493 - 498
  • [10] Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation
    Carlisle, Matthew A.
    Shrader, Peter
    Fudim, Marat
    Pieper, Karen S.
    Blanco, Rosalia G.
    Fonarow, Gregg C.
    Naccarelli, Gerald V.
    Gersh, Bernard J.
    Reiffel, James A.
    Kowey, Peter R.
    Steinberg, Benjamin A.
    Freeman, James V.
    Ezekowitz, Michael D.
    Singer, Daniel E.
    Allen, Larry A.
    Chan, Paul S.
    Pokorney, Sean D.
    Peterson, Eric D.
    Piccini, Jonathan P.
    HEART RHYTHM O2, 2022, 3 (06): : 621 - 628